Mergers and acquisitions – Page 2
-
Business
Chemicals industry roundup 2020
Pandemic provides impetus to re-tune supply chains for resilience and sustainability
-
Business
Pharmaceuticals roundup 2020
Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum
-
Business
AstraZeneca to buy rare disease drugmaker Alexion in $39bn deal
Transaction would be the largest in AstraZeneca’s history
-
Business
Ineos to buy BP petrochemicals businesses for $5bn
Deal covers 14 acetyls and aromatics manufacturing plants and 10 joint ventures
-
Business
Bayer commits over $10bn to resolve legacy Monsanto lawsuits
Agreement settles about 75% of Roundup-related cases and resolves PCB and dicamba litigation
-
Business
Pharmaceuticals roundup 2019
Under the shadow of political turmoil and major lawsuits, the industry returned to its strengths – making new drugs, and finding new ways to do it better
-
Business
Chemicals industry roundup 2019
Focus turns to sustainability amid rising economic pressures and political uncertainty
-
Business
Pfizer’s Upjohn to merge with Mylan
Deal combines Pfizer’s off-patent drug portfolio with Mylan’s generics
-
Business
US judges slash damages in glyphosate cancer lawsuits
While upholding rulings linking the herbicide to cancer, judges have cut Bayer-Monsanto’s fines from billions to tens of millions of dollars
-
Business
AbbVie to acquire Allergan in multibillion-dollar merger
Takeover deal will create world’s fifth-largest pharma company
-
Opinion
Is Bayer regretting its Monsanto takeover?
Large damages in Roundup litigation have got investors questioning the move
-
Business
Jury awards $2bn damages in US glyphosate trial
Bayer vows to appeal third defeat over Monsanto’s Roundup weedkiller, while experts suggest damages will likely be reduced
-
Business
Power-hungry Tesla picks up supercapacitor maker
Maxwell Technologies deal highlights potential for supercapacitors in electric vehicles and beyond
-
Business
Battling the US opioid epidemic
Adapt pharma’s naloxone nasal spray makes treating overdoses easier
-
Business
Bristol-Myers Squibb to buy Celgene for $74 billion
Deal boosts BMS’s cancer and immunology pipeline with 5 drugs in late stage clinical trials
-
Business
GSK and Pfizer joint venture creates new consumer healthcare giant
Enlarged GSK consumer health will have largest market share of any firm and be a leader in key countries
-
Business
Chemicals industry roundup 2018
Industry growth remains strong despite tariff disputes, political uncertainty and supply chain challenges
-
Business
Pharmaceuticals roundup 2018
Merger deals, product approvals and infrastructure changes have been overshadowed by political uncertainty, in Europe and around the world
-
Business
Bayer to cut 12000 jobs
As it integrates Monsanto businesses, Bayer will eliminate around 10% of its global workforce